Your browser doesn't support javascript.
loading
Targeting complete response with upfront bortezomib consolidation versus observation after the achievement of complete response following autologous transplantation for multiple myeloma (TUBA study).
Nakasone, Hideki; Terasako-Saito, Kiriko; Hirano, Teiichi; Wake, Atsushi; Shimizu, Seiichi; Kurita, Naoki; Yamazaki, Etsuko; Usuki, Kensuke; Akazawa, Kohei; Kanda, Junya; Minauchi, Koichiro; Yamamoto, Go; Tanimoto, Shiori; Kamoshita, Masaharu; Yokoyama, Yasuhisa; Miyaoka, Etsuo; Ota, Shuichi; Kako, Shinichi; Izutsu, Koji; Kanda, Yoshinobu.
Afiliação
  • Nakasone H; Division of Hematology, Saitama Medical Center, Jichi Medical University, Saitama, Japan.
  • Terasako-Saito K; Division of Hematology, Saitama Medical Center, Jichi Medical University, Saitama, Japan.
  • Hirano T; Department of Hematology, Sapporo Hokuyu Hospital, Sapporo, Japan.
  • Wake A; Department of Hematology, Toranomon Hospital Kajigaya, Kawasaki, Japan.
  • Shimizu S; Okinaka Memorial Institute of Medical Research, Tokyo, Japan.
  • Kurita N; Department of Hematology, Tsuchiura Kyodo General Hospital, Tsuchiura, Japan.
  • Yamazaki E; Department of Hematology, Faculty of Medicine, University of Tsukuba, Tsukuba, Japan.
  • Usuki K; Department of Hematology and Clinical Immunology, Yokohama City University Hospital, Yokohama, Japan.
  • Akazawa K; Clinical Laboratory Department, Yokohama City University Hospital, Yokohama, Japan.
  • Kanda J; Department of Hematology, NTT Medical Center Tokyo, Tokyo, Japan.
  • Minauchi K; Department of Medical Informatics, Niigata University Medical and Dental Hospital, Niigata, Japan.
  • Yamamoto G; Division of Hematology, Saitama Medical Center, Jichi Medical University, Saitama, Japan.
  • Tanimoto S; Department of Hematology, Sapporo Hokuyu Hospital, Sapporo, Japan.
  • Kamoshita M; Department of Hematology, Toranomon Hospital, Tokyo, Japan.
  • Yokoyama Y; Department of Hematology, Sapporo Hokuyu Hospital, Sapporo, Japan.
  • Miyaoka E; Department of Hematology, Tsuchiura Kyodo General Hospital, Tsuchiura, Japan.
  • Ota S; Department of Hematology, Faculty of Medicine, University of Tsukuba, Tsukuba, Japan.
  • Kako S; Department of Mathematics, Faculty of Science Division II, Tokyo University of Science, Tokyo, Japan.
  • Izutsu K; Department of Hematology, Sapporo Hokuyu Hospital, Sapporo, Japan.
  • Kanda Y; Division of Hematology, Saitama Medical Center, Jichi Medical University, Saitama, Japan.
Hematol Oncol ; 36(1): 202-209, 2018 Feb.
Article em En | MEDLINE | ID: mdl-28681529
Assuntos
Palavras-chave
Texto completo
Imprimir
XML
PubMed Links
Buscar no Google

Texto completo: 1 Coleções: 01-internacional Base de dados: MEDLINE Assunto principal: Protocolos de Quimioterapia Combinada Antineoplásica / Bortezomib / Mieloma Múltiplo Limite: Adult / Aged / Female / Humans / Male / Middle aged Idioma: En Ano de publicação: 2018 Tipo de documento: Article
Texto completo
Imprimir
XML
PubMed Links
Buscar no Google

Texto completo: 1 Coleções: 01-internacional Base de dados: MEDLINE Assunto principal: Protocolos de Quimioterapia Combinada Antineoplásica / Bortezomib / Mieloma Múltiplo Limite: Adult / Aged / Female / Humans / Male / Middle aged Idioma: En Ano de publicação: 2018 Tipo de documento: Article